Scyx stock zacks

Nov 01, 2019 · SCYX, Scynexis Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Scynexis Inc Stock Quote: SCYX Stock News, Quotes, Analysis | Investors.com SCYX | SCYNEXIS Inc. Analyst Estimates | MarketWatch Nov 07, 2019 · SCYNEXIS Inc. analyst estimates by MarketWatch. View SCYX revenue estimates and earnings estimates, as well as analyst recommendations.

Scynexis Inc Stock Quote: SCYX Stock News, Quotes ... Nov 01, 2019 · SCYX, Scynexis Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Scynexis Inc Stock Quote: SCYX Stock News, Quotes, Analysis | Investors.com SCYX | SCYNEXIS Inc. Analyst Estimates | MarketWatch Nov 07, 2019 · SCYNEXIS Inc. analyst estimates by MarketWatch. View SCYX revenue estimates and earnings estimates, as well as analyst recommendations. SCYX SCYNEXIS, Inc. Stock Quote - FINVIZ.com SCYNEXIS, Inc., a biotechnology company, delivers therapies for the treatment fungal infections in the United States. It is developing its lead product candidate, ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. Will SCYNEXIS Continue to Surge Higher? | Nasdaq

Get the latest SCYNEXIS, Inc. SCYX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Scynexis, Inc. - SCYX - Stock Price Today - Zacks SCYX is up 5.19% today,

Jan 09, 2020 · As of late, it has definitely been a great time to be an investor in SCYNEXIS, Inc. SCYX.The stock has moved higher by 22.5% in the past month, while it is also above its 20 Day SMA too. Scynexis (SCYX) Expected to Beat Earnings Estimates: Can ... May 07, 2019 · On the other hand, the stock currently carries a Zacks Rank of #3. So, this combination indicates that Scynexis will most likely beat the consensus EPS estimate. SCYX Stock | SCYNEXIS Stock Price Today | Markets Insider SCYX: Get the latest SCYNEXIS stock price and detailed information including SCYX news, historical charts and realtime prices. SCYX - Scynexis Stock Price - Barchart.com 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.

Common Stock|N| |N|100|N||CVX|CVX|N Y|CVY|Invesco Zacks Multi-Asset Inc. - Common Stock|Q|G|N|100|N|N||SCYX|N Y|SCZ|iShares MSCI EAFE 

Find the latest dividend history for SCYNEXIS, Inc. Common Stock (SCYX) at Nasdaq.com. Looking for additional market data? Zacks Investment Research, provides the upcoming ex-dividend dates SCYX - Scynexis Summary, Stock Quote and News | Benzinga Jan 01, 2010 · Scynexis (NASDAQ: SCYX) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. Scynexis (SCYX) Reports Q3 Loss, Tops Revenue Estimates ...

We certainly think that this might be the case, particularly if you consider SCYX's recen t earnings estimate revision activity. From this look, the company's future is quite favorable; as SCYX has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn't the top for the in-focus company.

The all-time high Jazz Pharmaceuticals stock closing price was 193.02 on July 28, 2015. The Jazz current share price. The average Jazz Pharmaceuticals stock price for the last 52 weeks is 132.70. SCYNEXIS (SCYX), United States, $0.082B, 0.00. Champions Fundamental data from Zacks Investment Research , Inc. 24 Jul 2017 Exchange Commission ("SEC") as a national stock exchange on June 17, 2016 and began business KraneShares Zacks New China ETF. PublicNASDAQSCYX (marketscreener.com) scyx-s8.htm As filed with the Securities and Exchange Commission on March 11, 20. January 8, 2020Zacks  

SCYX Stock Price, Forecast & News (SCYNEXIS) | MarketBeat

Nov 13, 2018 · Scynexis (SCYX) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of. SCYNEXIS, Inc. (SCYX) Dividend Date & History - Nasdaq

SCYX | SCYNEXIS Inc. Analyst Estimates | MarketWatch Nov 07, 2019 · SCYNEXIS Inc. analyst estimates by MarketWatch. View SCYX revenue estimates and earnings estimates, as well as analyst recommendations. SCYX SCYNEXIS, Inc. Stock Quote - FINVIZ.com SCYNEXIS, Inc., a biotechnology company, delivers therapies for the treatment fungal infections in the United States. It is developing its lead product candidate, ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. Will SCYNEXIS Continue to Surge Higher? | Nasdaq Jan 09, 2020 · As of late, it has definitely been a great time to be an investor in SCYNEXIS, Inc. SCYX. The stock has moved higher by 22.5% in the past month, while it is also above its 20 Day SMA too. This Analysts Estimate Scynexis (SCYX) to Report a Decline in ...